Tokyo, Japan

Takashi Yamamura

USPTO Granted Patents = 8 



Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 40(Granted Patents)


Location History:

  • Kokubunji, JP (2010 - 2011)
  • Tokyo, JP (2013 - 2023)

Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Takashi Yamamura: Innovator in Immunology

Introduction

Takashi Yamamura is a prominent inventor based in Tokyo, Japan, known for his significant contributions to the field of immunology. With a total of eight patents to his name, he has made remarkable advancements in the understanding and treatment of immune-related diseases.

Latest Patents

Among his latest patents are the GM-CSF-producing T-cell control agent and the Th1/Th2 immune balance regulator. The GM-CSF-producing T-cell control agent comprises a glycolipid compound represented by a specific formula, which plays a crucial role in T-cell regulation. Additionally, his invention for a prophylactic agent, onset-suppressing agent, or therapeutic agent for progressive immune demyelinating diseases focuses on substances that can suppress or inhibit the production of prolactin, showcasing his innovative approach to tackling complex health issues.

Career Highlights

Throughout his career, Takashi Yamamura has worked with esteemed institutions such as the National Center of Neurology and Psychiatry. His work at this institution has been pivotal in advancing research in neurology and psychiatry, contributing to the development of new therapeutic strategies.

Collaborations

Takashi has collaborated with notable colleagues, including Hirokazu Annoura and Kenji Murata. Their joint efforts have further enriched the research landscape in immunology and related fields.

Conclusion

In summary, Takashi Yamamura's innovative work and patents have significantly impacted the field of immunology, particularly in the treatment of immune-related diseases. His contributions continue to inspire advancements in medical research and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…